Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
TGTX - REVENUE
Revenue TGTX - TG Therapeutics, Inc.
234 M
LAST VALUE
491.04%
2 YEAR CAGR
333.86%
5 YEAR CAGR
108.24%
10 YEAR CAGR